ADORA2A and Parkinson disease: To assess the suitability of PET for detection of changes in the availability of A2AR in PD, our group performed dynamic PET studies in a rotenone-based mouse model of Parkinson’s disease with [18F]MRS5425, (also known as [18F]FESCH) [15,16].